跳至主要内容
临床试验/NCT04487275
NCT04487275Unknown4 期

MLC901 for Moderate to Severe Traumatic Brain Injury: Pilot, Randomized, Double-Masked, Placebo-controlled Trial

Ali Amini Harandi1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年8月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
80
试验地点
1
主要终点
functional outcome 5

研究概览

简要总结

Patients with a diagnosis of moderate to severe traumatic brain injury (TBI) will be enrolled. Subjects will be randomly assigned to receive either MLC901 (Specified Drug Code) or placebo capsules three times per day over 6 months. Evaluation of patients will be carried out at baseline as well as at 3-month and 6-month follow-up visits. Modified Rankin Scale (mRS) and Glasgow outcome scale (GOS) will be used to examine patients. Efficacy will be evaluated by comparing these two scores between the 2 groups at follow-up visits.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
15 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age between 15 and 65
  • non-penetrating moderate (Glasgow Coma Scale score [GCS] 9-12) or severe (GCS 3-8) traumatic brain
  • injury less than 24 hrs from traumatic injury
  • anticipated intensive care unit length of stay at least 48 hrs

排除标准

  • GCS = 3 and fixed dilated pupils or penetrating injury
  • coexisting injury or medical conditions which could adversely affect our study outcome measures
  • dependence for everyday activities before the injury
  • pregnancy or breastfeeding
  • known allergy to any of MLC901 components

研究组 & 干预措施

Drug

Experimental

MLC901 capsules three times per day over 6 months

干预措施: MLC901 or Placebo (Drug)

Placebo

Placebo Comparator

Placebo capsules three times per day over 6 months

干预措施: MLC901 or Placebo (Drug)

结局指标

主要结局

functional outcome 5

时间窗: at 3rd month post-injury

functional outcome scales of MRS

functional outcome 1

时间窗: at baseline

functional outcome scales of GOS

functional outcome 2

时间窗: at 3rd month post-injury

functional outcome scales of GOS

functional outcome 3

时间窗: at 6th month post-injury

functional outcome scales of GOS

functional outcome 6

时间窗: at 6th month post-injury

functional outcome scales of MRS

functional outcome 4

时间窗: at baseline

functional outcome scales of MRS

次要结局

未报告次要终点

研究者

发起方
Ali Amini Harandi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ali Amini Harandi

Prof

Shahid Beheshti University

研究点 (1)

Loading locations...

相似试验